PL2221309T3 - Monohydrat pochodnej naftyrydyny i sposób jego wytwarzania - Google Patents

Monohydrat pochodnej naftyrydyny i sposób jego wytwarzania

Info

Publication number
PL2221309T3
PL2221309T3 PL08855286T PL08855286T PL2221309T3 PL 2221309 T3 PL2221309 T3 PL 2221309T3 PL 08855286 T PL08855286 T PL 08855286T PL 08855286 T PL08855286 T PL 08855286T PL 2221309 T3 PL2221309 T3 PL 2221309T3
Authority
PL
Poland
Prior art keywords
producing
same
naphthyridine derivative
monohydrate
derivative monohydrate
Prior art date
Application number
PL08855286T
Other languages
English (en)
Inventor
Taro Kiyoto
Masahiro Takebayashi
Yasutaka Baba
Muneo Syoji
Toshiya Noguchi
Fumihito Ushiyama
Hiroki Urabe
Hiromasa Horikiri
Original Assignee
Toyama Chemical Co Ltd
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd, Taisho Pharmaceutical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of PL2221309T3 publication Critical patent/PL2221309T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL08855286T 2007-11-26 2008-11-25 Monohydrat pochodnej naftyrydyny i sposób jego wytwarzania PL2221309T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007304736 2007-11-26
EP08855286.4A EP2221309B1 (en) 2007-11-26 2008-11-25 Naphthyridine derivative monohydrate and method for producing the same
PCT/JP2008/071333 WO2009069589A1 (ja) 2007-11-26 2008-11-25 新規なナフチリジン誘導体１水和物およびその製造法

Publications (1)

Publication Number Publication Date
PL2221309T3 true PL2221309T3 (pl) 2013-12-31

Family

ID=40678484

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08855286T PL2221309T3 (pl) 2007-11-26 2008-11-25 Monohydrat pochodnej naftyrydyny i sposób jego wytwarzania

Country Status (20)

Country Link
US (1) US8354426B2 (pl)
EP (1) EP2221309B1 (pl)
JP (1) JP5491195B2 (pl)
KR (1) KR20100088693A (pl)
CN (1) CN101874032B (pl)
AU (1) AU2008330725B2 (pl)
BR (1) BRPI0820394A2 (pl)
CA (1) CA2706929A1 (pl)
CY (1) CY1114936T1 (pl)
DK (1) DK2221309T3 (pl)
ES (1) ES2426593T3 (pl)
HR (1) HRP20130860T1 (pl)
IL (1) IL205849A0 (pl)
MX (1) MX2010005725A (pl)
NZ (1) NZ585529A (pl)
PL (1) PL2221309T3 (pl)
PT (1) PT2221309E (pl)
SI (1) SI2221309T1 (pl)
WO (1) WO2009069589A1 (pl)
ZA (1) ZA201003507B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1900732A4 (en) 2005-06-24 2009-11-18 Toyama Chemical Co Ltd NEW NITROGENATED HETEROCYCLIC COMPOUND AND SALT THEREOF
AU2007268749B2 (en) 2006-05-26 2012-07-26 Taisho Pharmaceutical Co., Ltd. Novel heterocyclic compound or salt thereof and intermediate thereof
AU2009325902B2 (en) 2008-12-12 2015-01-29 Idorsia Pharmaceuticals Ltd 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives
TW201326180A (zh) 2011-11-30 2013-07-01 Actelion Pharmaceuticals Ltd ３，７－二取代八氫－２Ｈ－吡啶并［４，３－ｅ］［１，３］□嗪－２－酮抗生素
US9863798B2 (en) 2015-02-27 2018-01-09 Schneider Electric Systems Usa, Inc. Systems and methods for multiphase flow metering accounting for dissolved gas

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999007682A1 (en) 1997-08-08 1999-02-18 Toyama Chemical Co., Ltd. Quinolonecarboxylic acid derivatives or salts thereof
GB0031088D0 (en) 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
AR040336A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
AR042486A1 (es) * 2002-12-18 2005-06-22 Glaxo Group Ltd Compuesto de quinolina y naftiridina halosustituido en la posicion 3, procedimiento para preparar el compuesto, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion .
EP1471063A1 (en) * 2003-02-28 2004-10-27 Exonhit Therapeutics S.A. Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis
MY150958A (en) * 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
ATE465163T1 (de) 2005-12-22 2010-05-15 Glaxo Group Ltd Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel
EP2001887B1 (en) * 2006-04-06 2010-09-15 Glaxo Group Limited Pyrrolo-quinoxalinone derivatives as antibacterials
AU2007268749B2 (en) 2006-05-26 2012-07-26 Taisho Pharmaceutical Co., Ltd. Novel heterocyclic compound or salt thereof and intermediate thereof
EP1992628A1 (en) * 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
PE20081551A1 (es) * 2006-07-20 2009-01-09 Glaxo Group Ltd Derivados de quinolona como antibacterianos

Also Published As

Publication number Publication date
PT2221309E (pt) 2013-10-01
EP2221309A1 (en) 2010-08-25
JP5491195B2 (ja) 2014-05-14
KR20100088693A (ko) 2010-08-10
EP2221309B1 (en) 2013-07-24
IL205849A0 (en) 2010-11-30
CN101874032A (zh) 2010-10-27
US8354426B2 (en) 2013-01-15
DK2221309T3 (da) 2013-10-07
NZ585529A (en) 2012-05-25
BRPI0820394A2 (pt) 2015-05-19
MX2010005725A (es) 2011-04-11
EP2221309A4 (en) 2011-11-09
RU2010126085A (ru) 2012-01-10
CY1114936T1 (el) 2016-12-14
AU2008330725A1 (en) 2009-06-04
WO2009069589A1 (ja) 2009-06-04
ES2426593T3 (es) 2013-10-24
AU2008330725B2 (en) 2013-05-30
HK1145179A1 (en) 2011-04-08
CA2706929A1 (en) 2009-06-04
US20100249417A1 (en) 2010-09-30
CN101874032B (zh) 2013-02-06
ZA201003507B (en) 2011-07-27
JPWO2009069589A1 (ja) 2011-04-14
HRP20130860T1 (en) 2013-10-11
SI2221309T1 (sl) 2013-10-30

Similar Documents

Publication Publication Date Title
IL271761A (en) History of benzodiazepines and processes for their preparation
EP2142111A4 (en) METHOD AND DEVICE FOR FORMING MULTIPLE MICROPECTS
EP2205914A4 (en) FOOD STORAGE APPARATUS AND METHOD OF MANUFACTURE
IL197129A0 (en) Controlled release system and method for manufacturing the same
PL1903019T3 (pl) Sposób wytwarzania izoolefin
PL2358669T3 (pl) Alfa-ketonadkwasy oraz metody ich produkcji i wykorzystywania
PL1981768T3 (pl) Worek i sposób wytwarzania go
EP2234626A4 (en) METHOD AND MEANS FOR PRODUCING BRONCHORELAXATION
EP2138168A4 (en) ORAL ADMINISTRATION AGENT AND METHOD FOR PRODUCING THE SAME
PL2346493T3 (pl) Tabletki wielocząstkowe i sposób ich wytwarzania
ZA201002297B (en) Improved method for producing diesters
PL2265415T3 (pl) Sposób nierozłącznego łączenia elementów
EP1972615A4 (en) CYCLOALCANECARBOXAMIDE DERIVATIVE AND METHOD FOR PRODUCING THE SAME
GB0625842D0 (en) Indolizine derivatives
EP2156827A4 (en) CATAPLASM AND PROCESS FOR PRODUCTION OF CATAPLASM
ZA201003507B (en) Novel naphthyridine derivative monohydrate and method for producing the same
ZA201000566B (en) Rolling devic and method for the operation thereof
GB2455464B (en) Semiconductor and method for producing the same
PL2155679T3 (pl) Sposób wytwarzania pochodnych 4-formyloaminopiperydyny
PL2288500T3 (pl) Laminat i sposób jego wytwarzania
EP2253634A4 (en) LIQUID PORPHYRINE DERIVATIVE AND MANUFACTURING METHOD THEREFOR
EP2065450A4 (en) CRAYON AND METHOD FOR PRODUCING THE SAME
EP2067832A4 (en) CRAYON AND METHOD FOR PRODUCING THE SAME
EP2233609A4 (de) Lichtabsorbierendes element und herstellungsverfahren dafür
IL204792A0 (en) Method for producing pyrazolinone derivative